These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23883384)

  • 21. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
    Matyas GR; Wieczorek L; Beck Z; Ochsenbauer-Jambor C; Kappes JC; Michael NL; Polonis VR; Alving CR
    AIDS; 2009 Oct; 23(16):2069-77. PubMed ID: 19710597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Broadly Neutralizing Antibodies and the Development of Vaccines.
    Haynes BF; Bradley T
    JAMA; 2015 Jun 23-30; 313(24):2419-20. PubMed ID: 26103022
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV: Sequential vaccine elicits broadly neutralizing antibodies.
    Flemming A
    Nat Rev Drug Discov; 2016 Nov; 15(11):748-749. PubMed ID: 27807354
    [No Abstract]   [Full Text] [Related]  

  • 24. Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines.
    Albert J; Chiodi F; Fenyö EM
    J Intern Med; 2007 Jul; 262(1):2-4. PubMed ID: 17598811
    [No Abstract]   [Full Text] [Related]  

  • 25. HIV neutralizing antibodies: clinical correlates and implications for vaccines.
    Doria-Rose NA
    J Infect Dis; 2010 Apr; 201(7):981-3. PubMed ID: 20170372
    [No Abstract]   [Full Text] [Related]  

  • 26. Broadly neutralizing antibodies against HIV-1: templates for a vaccine.
    van Gils MJ; Sanders RW
    Virology; 2013 Jan; 435(1):46-56. PubMed ID: 23217615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The new vaccine challenges of "humanization" of HIV].
    Nau JY
    Rev Med Suisse; 2013 Aug; 9(394):1490-1. PubMed ID: 24024395
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines.
    Evans TG; Frey S; Israel H; Chiu J; El-Habib R; Gilbert P; Gaitan A; Montefiori DC;
    Vaccine; 2004 Jun; 22(20):2626-30. PubMed ID: 15193388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Origins of a Vaccine-Induced, Human Anti-HIV-1 Antibody.
    Julien JP
    EBioMedicine; 2015 Jul; 2(7):632-3. PubMed ID: 26288832
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV surface proteins finally caught going au naturel.
    Cohen J
    Science; 2013 Nov; 342(6158):546-7. PubMed ID: 24179198
    [No Abstract]   [Full Text] [Related]  

  • 31. Remodeling of dynamic structures of HIV-1 envelope proteins leads to synthetic antigen molecules inducing neutralizing antibodies.
    Nakahara T; Nomura W; Ohba K; Ohya A; Tanaka T; Hashimoto C; Narumi T; Murakami T; Yamamoto N; Tamamura H
    Bioconjug Chem; 2010 Apr; 21(4):709-14. PubMed ID: 20359196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translating antibody insights.
    Gerberding JL
    Science; 2013 Sep; 341(6151):1151. PubMed ID: 24030986
    [No Abstract]   [Full Text] [Related]  

  • 33. Roads less taken.
    McEnery R
    IAVI Rep; 2013; 17(2):13-8. PubMed ID: 23858548
    [No Abstract]   [Full Text] [Related]  

  • 34. The path to protection. Clinical trials both past and present are contributing to the design of new and improved HIV vaccine immunogens.
    Bajaria SH
    IAVI Rep; 2014; 18(2):12-4. PubMed ID: 25102680
    [No Abstract]   [Full Text] [Related]  

  • 35. Infectious diseases: Two-pronged attack on HIV.
    Kingwell K
    Nat Rev Drug Discov; 2016 Aug; 15(8):529. PubMed ID: 27444225
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV-1 vaccine--many miles to go before we sleep.
    Jeang KT; Huang LM
    J Formos Med Assoc; 2009 Nov; 108(11):827-9. PubMed ID: 19933024
    [No Abstract]   [Full Text] [Related]  

  • 37. Ushering along B cells to neutralize HIV.
    Agazio A; Torres RM
    Science; 2019 Dec; 366(6470):1197-1198. PubMed ID: 31806801
    [No Abstract]   [Full Text] [Related]  

  • 38. Getting the vaccine strategy right in HIV-1 disease.
    Rowe PM
    Lancet; 1997 May; 349(9063):1454. PubMed ID: 9164329
    [No Abstract]   [Full Text] [Related]  

  • 39. New results may help design effective HIV-1 vaccine.
    Morris K
    Lancet; 1999 Feb; 353(9151):471. PubMed ID: 9989729
    [No Abstract]   [Full Text] [Related]  

  • 40. Uhambo - Twists and Turns on the Journey to an Efficacious HIV-1 Vaccine.
    Feinberg MB
    N Engl J Med; 2021 Mar; 384(12):1157-1159. PubMed ID: 33761212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.